Acta Neuropathologica

Article	Citations
HnRNP K mislocalisation is a novel protein pathology of frontotemporal lobar degeneration and ageing and leads to cryptic splicing	355
Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy	208
Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD	172
Impaired GABAergic regulation and developmental immaturity in interneurons derived from the medial ganglionic eminence in the tuberous sclerosis complex	120
A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies	119
The prevalence and topography of spinal cord demyelination in multiple sclerosis: a retrospective study	116
More than a co-incidence? Comment on: Amyotrophic lateral sclerosis is over‐represented in two Huntington’s disease brain bank cohorts: further evidence to support genetic pleiotropy of pathogenic HTT	112
Increased NF-L levels in the TDP-43G298S ALS mouse model resemble NF-L levels in ALS patients	99
Somatic mosaic SOX10 indel mutations underlie a form of segmental schwannomatosis	97
Pineal parenchymal tumors of intermediate differentiation: in need of a stringent definition to avoid confusion. Scientific commentary on ‘Genetical and epigenetical profiling identifies two subgroups	94
Lack of evidence supporting a role for DPP6 sequence variants in Alzheimer’s disease in the European American population	92
Associations of CSF BACE1 with amyloid pathology, neurodegeneration, and cognition in Alzheimer’s disease	90
Reply: ATP10B variants in Parkinson’s disease—a large cohort study in Chinese mainland population	80
Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes	78
Persistent virus-specific and clonally expanded antibody-secreting cells respond to induced self-antigen in the CNS	74
Epigenetic and gene expression changes of neuronal cells from MSA patients are pronounced in enzymes for cell metabolism and calcium-regulated protein kinases	71
Gene transcript fusions are associated with clinical outcomes and molecular groups of meningiomas	68
Strain diversity in neurodegenerative disease: an argument for a personalized medicine approach to diagnosis and treatment	65
Cortical-sparing chronic traumatic encephalopathy (CSCTE): a distinct subtype of CTE	64
Tau seeds occur before earliest Alzheimer’s changes and are prevalent across neurodegenerative diseases	62
EWSR1-BEND2 fusion defines an epigenetically distinct subtype of astroblastoma	60
Spatial immune profiling of glioblastoma identifies an inflammatory, perivascular phenotype associated with longer survival	56
Regional AT-8 reactive tau species correlate with intracellular Aβ levels in cases of low AD neuropathologic change	56
IL-10-providing B cells govern pro-inflammatory activity of macrophages and microglia in CNS autoimmunity	54
Single-nucleus chromatin accessibility profiling highlights distinct astrocyte signatures in progressive supranuclear palsy and corticobasal degeneration	52

Abundant transcriptomic alterations in the human cerebellum of patients with a C9orf72 repeat expansion	52
Blood-based Aβ42 increases in the earliest pre-pathological stage before decreasing with progressive amyloid pathology in preclinical models and human subjects: opening new avenues for prevention	51
Intratumor and informatic heterogeneity influence meningioma molecular classification	50
Stage-dependent immunity orchestrates AQP4 antibody-guided NMOSD pathology: a role for netting neutrophils with resident memory T cells in situ	50
Co-registration of MALDI-MSI and histology demonstrates gangliosides co-localize with amyloid beta plaques in Alzheimer’s disease	49
From shape to contents: heterogeneity of CNS glial cells	46
Clinically unfavorable transcriptome subtypes of non-WNT/non-SHH medulloblastomas are associated with a predominance in proliferating and progenitor-like cell subpopulations	45
TMEM106B coding variant is protective and deletion detrimental in a mouse model of tauopathy	45
Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signalling	45
Wolframin is a novel regulator of tau pathology and neurodegeneration	41
Rare genetic variation in fibronectin 1 (FN1) protects against APOEε4 in Alzheimer’s disease	39
Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer’s Coordinating Center database	39
Targeting fibroblast growth factor receptors to combat aggressive ependymoma	38
EZHIP: a new piece of the puzzle towards understanding pediatric posterior fossa ependymoma	38
Capillary basement membrane reduplication in myositis patients with mild clinical features of systemic sclerosis supports the concept of ‘scleromyositis’	38
Pituitary neuroendocrine tumors with PIT1/SF1 co-expression show distinct clinicopathological and molecular features	38
A network of core and subtype-specific gene expression programs in myositis	37
AR cooperates with SMAD4 to maintain skeletal muscle homeostasis	36
Clinical and neuropathological diversity of tauopathy in MAPT duplication carriers	35
The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers	35
Endothelial cells and macrophages as allies in the healthy and diseased brain	34
Alternatively spliced ELAVL3 cryptic exon 4a causes ELAVL3 downregulation in ALS TDP-43 proteinopathy	34
Dominant-acting CSF1R variants cause microglial depletion and altered astrocytic phenotype in zebrafish and adult-onset leukodystrophy	34
Macrophages and endothelial cells in the neurovascular unit	34
Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s disease	34
Oncohistone interactome profiling uncovers contrasting oncogenic mechanisms and identifies potential therapeutic targets in high grade glioma	33
Mutant LRRK2 exacerbates immune response and neurodegeneration in a chronic model of experimental colitis	33
Comparing amyloid-β plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease	32
Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy	32
R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils	32
Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab	32
Association of small vessel disease with tau pathology	31
Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementia	31
Evidence of traumatic brain injury in headbutting bovids	29
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden	29
Loss of TDP-43 splicing repression occurs early in the aging population and is associated with Alzheimer’s disease neuropathologic changes and cognitive decline	29
Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau	29
Loss of function variants in DNAJB4 cause a myopathy with early respiratory failure	28
Optimal blood tau species for the detection of Alzheimer’s disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study	28
Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1	28
Perivascular space dilation is associated with vascular amyloid-β accumulation in the overlying cortex	28
Aberrant NOVA1 function disrupts alternative splicing in early stages of amyotrophic lateral sclerosis	28
Loss of TMEM106B exacerbates Tau pathology and neurodegeneration in PS19 mice	27
AMFR dysfunction causes autosomal recessive spastic paraplegia in human that is amenable to statin treatment in a preclinical model	27
Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease	27
The oncogenic fusion landscape in pediatric CNS neoplasms	27
Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology	27
Correction to: Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS	26
Correction to: Accumulation of TMEM106B C‑terminal fragments in neurodegenerative disease and aging	26
Regulated cell death and its role in Alzheimer’s disease and amyotrophic lateral sclerosis	26

Correction to: Flow blockage disrupts cilia-driven fluid transport in the epileptic brain	26
Correction to: Archeological neuroimmunology: resurrection of a pathogenic immune response from a historical case sheds light on human autoimmune encephalomyelitis and multiple sclerosis	26
A novel subtype of sporadic Creutzfeldt–Jakob disease with PRNP codon 129MM genotype and PrP plaques	26
Metabologenomic characterization uncovers a clinically aggressive IDH mutant glioma subtype	25
Adaptive structural changes in the motor cortex and white matter in Parkinson’s disease	25
Neuronal tau pathology worsens late-phase white matter degeneration after traumatic brain injury in transgenic mice	24
Disruption of the blood–brain barrier is correlated with spike endocytosis by ACE2 + endothelia in the CNS microvasculature in fatal COVID-19. Scientific commentary on "Detection of blood–brain barrie	24
Tuberous sclerosis complex is associated with a novel human tauopathy	24
Neuronal spreading and plaque induction of intracellular Aβ and its disruption of Aβ homeostasis	24
Heterogeneity in α-synuclein fibril activity correlates to disease phenotypes in Lewy body dementia	24
Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma development	24
Microglia activation in periplaque white matter in multiple sclerosis depends on age and lesion type, but does not correlate with oligodendroglial loss	24
Altered oligodendroglia and astroglia in chronic traumatic encephalopathy	23
Concussion leads to widespread axonal sodium channel loss and disruption of the node of Ranvier	23
Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytoma	22
Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS-FTD spectrum	22
Clinically relevant molecular hallmarks of PFA ependymomas display intratumoral heterogeneity and correlate with tumor morphology	22
Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors	22
Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry	22
Fatal encephalitis caused by Newcastle disease virus in a child	22
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts	22
Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer’s disease pathology progression	22
Recurrent ACVR1 mutations in posterior fossa ependymoma	22
Correction to: Dysregulation of astrocytic Ca2+ signaling and gliotransmitter release in mouse models of α-synucleinopathies	21
Circular RNA profiling distinguishes medulloblastoma groups and shows aberrant RMST overexpression in WNT medulloblastoma	21
BTK inhibition limits microglia-perpetuated CNS inflammation and promotes myelin repair	21
Chronic traumatic encephalopathy (CTE): criteria for neuropathological diagnosis and relationship to repetitive head impacts	21
Dysregulation of astrocytic Ca2+ signaling and gliotransmitter release in mouse models of α-synucleinopathies	21
Genetic and epigenetic characterization of posterior pituitary tumors	21
Reply: Soluble oligomers or insoluble fibrils?	21
Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration	21
Brain region-specific susceptibility of Lewy body pathology in synucleinopathies is governed by α-synuclein conformations	21
Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas	21
Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas	21
A muscarinic receptor antagonist reverses multiple indices of diabetic peripheral neuropathy: preclinical and clinical studies using oxybutynin	20
NTRK rearrangements in a subset of NF1-related malignant peripheral nerve sheath tumors as novel actionable target	20
Tau filaments with the chronic traumatic encephalopathy fold in a case of vacuolar tauopathy with VCP mutation D395G	20
Single-cell DNA sequencing reveals order of mutational acquisition in TRAF7/AKT1 and TRAF7/KLF4 mutant meningiomas	20
Malignant gliomas with H3F3A G34R mutation or MYCN amplification in pediatric patients with Li Fraumeni syndrome	20
Alteration of LARGE1 abundance in patients and a mouse model of 5q-associated spinal muscular atrophy	20
Huntington’s disease brain-derived small RNAs recapitulate associated neuropathology in mice	19
MET receptor serves as a promising target in melanoma brain metastases	19
Correction to: Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43	19
Cryo-EM structures of tau filaments from Alzheimer’s disease with PET ligand APN-1607	18
Mutations in ARHGEF15 cause autosomal dominant hereditary cerebral small vessel disease and osteoporotic fracture	18
Genetic and epigenetic profiling identifies two distinct classes of spinal meningiomas	18
Characterization of NEB pathogenic variants in patients reveals novel nemaline myopathy disease mechanisms and omecamtiv mecarbil force effects	18
Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis	18
Cryptic exon inclusion is a molecular signature of LATE-NC in aging brains	18
Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer’s disease	18
Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients	18
ATP10B variants in Parkinson’s disease: a large cohort study in Chinese mainland population	17
Defective cerebellar ryanodine receptor type 1 and endoplasmic reticulum calcium ‘leak’ in tremor pathophysiology	17
Selective tau seeding assays and isoform-specific antibodies define neuroanatomic distribution of progressive supranuclear palsy pathology arising in Alzheimer’s disease	17
TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma	17
RNA aptamer reveals nuclear TDP-43 pathology is an early aggregation event that coincides with STMN-2 cryptic splicing and precedes clinical manifestation in ALS	17
Early and selective localization of tau filaments to glutamatergic subcellular domains within the human anterodorsal thalamus	17
Somatic LINE-1 promoter acquisition drives oncogenic FOXR2 activation in pediatric brain tumor	17
A familial missense variant in the Alzheimer’s disease gene SORL1 impairs its maturation and endosomal sorting	17
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum	16
Decreased dystrophin expression and elevated dystrophin-targeting miRNAs in anti-HMGCR immune-mediated necrotizing myopathy	16
Correction to: Single‑cell profiling of myasthenia gravis identifies a pathogenic T cell signature	16
TDP-43 interacts with pathological τ protein in Alzheimer’s disease	16
A T-cell antigen atlas for meningioma: novel options for immunotherapy	16
Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study	16
RNA methyltransferase NSun2 deficiency promotes neurodegeneration through epitranscriptomic regulation of tau phosphorylation	16
BTK inhibition limits B-cell–T-cell interaction through modulation of B-cell metabolism: implications for multiple sclerosis therapy	16
Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease	16
Seeding activity of human superoxide dismutase 1 aggregates in familial and sporadic amyotrophic lateral sclerosis postmortem neural tissues by real-time quaking-induced conversion	16
Missense mutations in small muscle protein X-linked (SMPX) cause distal myopathy with protein inclusions	16
Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations	16
An interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS/FTD	16
Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma	15
Even heterozygous loss of CDKN2A/B greatly accelerates recurrence in aggressive meningioma	15
A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4	15
TREM2 gene expression associations with Alzheimer’s disease neuropathology are region-specific: implications for cortical versus subcortical microglia	15
Correction to: Limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) is independently associated with dementia and strongly associated with arteriolosclerosis in the	15
p-tau Ser356 is associated with Alzheimer’s disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003	15
SCN1A overexpression, associated with a genomic region marked by a risk variant for a common epilepsy, raises seizure susceptibility	15
A novel ATXN1-DUX4 fusion expands the spectrum of ‘CIC-rearranged sarcoma’ of the CNS to include non-CIC alterations	15

Cross-platform transcriptional profiling identifies common and distinct molecular pathologies in Lewy body diseases	15
New SNCA mutation and structures of α-synuclein filaments from juvenile-onset synucleinopathy	15
Associations of psychiatric disease and ageing with FKBP5 expression converge on superficial layer neurons of the neocortex	15
Nuclear depletion of RNA-binding protein ELAVL3 (HuC) in sporadic and familial amyotrophic lateral sclerosis	15
Cryo-EM structures of amyloid-β filaments with the Arctic mutation (E22G) from human and mouse brains	15
A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer’s disease	15
Analysis of inflammatory markers and tau deposits in an autopsy series of nine patients with anti-IgLON5 disease	15
Oligodendroglia heterogeneity in the human central nervous system	14
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease	14
Hemorrhagic lesion with detection of infected endothelial cells in human bornavirus encephalitis	14
More than meets the eye in Parkinson’s disease and other synucleinopathies: from proteinopathy to lipidopathy	14
Phenotypic diversity of genetic Creutzfeldt–Jakob disease: a histo-molecular-based classification	14
Characterisation of premature cell senescence in Alzheimer’s disease using single nuclear transcriptomics	14
Detection of blood–brain barrier disruption in brains of patients with COVID-19, but no evidence of brain penetration by SARS-CoV-2	14
Decreased FAK activity and focal adhesion dynamics impair proper neurite formation of medium spiny neurons in Huntington's disease	13
TDP-43 drives synaptic and cognitive deterioration following traumatic brain injury	13
Soluble oligomers or insoluble fibrils? Scientific commentary on “Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau”	13
Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies	13
Complement activation contributes to GAD antibody-associated encephalitis	13
Alzheimer’s disease neuropathological change three decades after iatrogenic amyloid-β transmission	13
Variant allelic frequency of driver mutations predicts success of genomic DNA methylation classification in central nervous system tumors	13
Early white matter pathology in the fornix of the limbic system in Huntington disease	13
Patterns of neuronal Rhes as a novel hallmark of tauopathies	13
APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer’s disease with Lewy body pathology	13
New evidence suggests SARS-CoV-2 neuroinvasion along the nervus terminalis rather than the olfactory pathway	12
TREM2 expression in the brain and biological fluids in prion diseases	12
Complement and MHC patterns can provide the diagnostic framework for inflammatory neuromuscular diseases	12
PLAG1 fusions extend the spectrum of PLAG(L)-altered CNS tumors	12
Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation	12
Progranulin deficiency results in sex-dependent alterations in microglia in response to demyelination	12
Altered TFEB subcellular localization in nigral neurons of subjects with incidental, sporadic and GBA-related Lewy body diseases	12
Retinal pathological features and proteome signatures of Alzheimer’s disease	12
Histopathologic brain age estimation via multiple instance learning	12
Expanding the phenotype and genotype spectra of PLIN4-associated myopathy with rimmed ubiquitin-positive autophagic vacuolation	12
The Alzheimer’s disease GWAS risk alleles in the ABCA7 promoter and 5’ region reduce ABCA7 expression	12
Mitochondrial damage and impaired mitophagy contribute to disease progression in SCA6	12
Increased pyroptosis activation in white matter microglia is associated with neuronal loss in ALS motor cortex	12
Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations	12
Loss of LAMP5 interneurons drives neuronal network dysfunction in Alzheimer’s disease	12
Aggressive human MenG C meningiomas have a molecular counterpart in canines	11
Neuroinflammatory disease signatures in SPG11-related hereditary spastic paraplegia patients	11
G2C4 targeting antisense oligonucleotides potently mitigate TDP-43 dysfunction in human C9orf72 ALS/FTD induced pluripotent stem cell derived neurons	11
Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS	11
Emerging concepts in synucleinopathies	11
Aminopeptidase A contributes to biochemical, anatomical and cognitive defects in Alzheimer’s disease (AD) mouse model and is increased at early stage in sporadic AD brain	11
Loss of the heterogeneous expression of flippase ATP11B leads to cerebral small vessel disease in a normotensive rat model	11
Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas	11
Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics	11
TDP-43 pathology in the retina of patients with frontotemporal lobar degeneration	11
Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas	11
Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer’s disease and primary tauopathies	11
Systemic sclerosis-associated myositis features minimal inflammation and characteristic capillary pathology	10
Cortical matrix remodeling as a hallmark of relapsing–remitting neuroinflammation in MR elastography and quantitative MRI	10
Spatiotemporal characterization of cellular tau pathology in the human locus coeruleus–pericoerulear complex by three-dimensional imaging	10
PP2A and GSK3 act as modifiers of FUS-ALS by modulating mitochondrial transport	10
Widespread CNS pathology in amyotrophic lateral sclerosis homozygous for the D90A SOD1 mutation	10
Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges	10
Urinary tract infections trigger synucleinopathy via the innate immune response	10
Heteroplasmic mitochondrial DNA mutations in frontotemporal lobar degeneration	10
Reply: pineal parenchymal tumors of intermediate differentiation: in need of a stringent definition to avoid confusion	10
Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging	10
TBK1 haploinsufficiency in ALS and FTD compromises membrane trafficking	10
Cell-specific MAPT gene expression is preserved in neuronal and glial tau cytopathologies in progressive supranuclear palsy	10
Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomics	10
Molecular characteristics and improved survival prediction in a cohort of 2023 ependymomas	10
Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1	9
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease	9
DNA-methylation subgroups carry no prognostic significance in ATRT-SHH patients in clinical trial cohorts	9
SMARCA4-associated schwannomatosis	9
Identification of TMEM106B amyloid fibrils provides an updated view of TMEM106B biology in health and disease	9
Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology	9
Complement component 3 from astrocytes mediates retinal ganglion cell loss during neuroinflammation	9
Multi-level profiling unravels mitochondrial dysfunction in myotonic dystrophy type 2	9
Characterization of hippocampal sclerosis of aging and its association with other neuropathologic changes and cognitive deficits in the oldest-old	9
PSD-93 up-regulates the synaptic activity of corticotropin-releasing hormone neurons in the paraventricular nucleus in depression	9
Proteomic identification of select protein variants of the SNARE interactome associated with cognitive reserve in a large community sample	9
Landscape of brain myeloid cell transcriptome along the spatiotemporal progression of Alzheimer’s disease reveals distinct sequential responses to Aβ and tau	8
Role of GBA variants in Lewy body disease neuropathology	8
Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions	8
Transmission experiments verify sporadic V2 prion in a patient with E200K mutation	8
Jorge Cervós-Navarro 1930–2021	8
Cross-β helical filaments of Tau and TMEM106B in gray and white matter of multiple system tauopathy with presenile dementia	8
DNA methylation analysis of glioblastomas harboring FGFR3-TACC3 fusions identifies a methylation subclass with better patient survival	8
Spinal astrocyte dysfunction drives motor neuron loss in late-onset spinal muscular atrophy	8
Histopathology of the cerebellar cortex in essential tremor and other neurodegenerative motor disorders: comparative analysis of 320 brains	8
A tribute to Paul Kleihues, M.D. (1936–2022)	8
Structure of Tau filaments in Prion protein amyloidoses	8
John Q. Trojanowski: neuropathology icon	8
Clinical applicability of miR517a detection in liquid biopsies of ETMR patients	8
Variants in DTNA cause a mild, dominantly inherited muscular dystrophy	8
Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis	8
Regional distribution and maturation of tau pathology among phenotypic variants of Alzheimer’s disease	8
DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastoma	8